Literature DB >> 5115035

Suxamethonium-induced cardiac arrest in unsuspected pseudohypertrophic muscular dystrophy. Case report.

E E Genever.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5115035     DOI: 10.1093/bja/43.10.984

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  9 in total

1.  Hyperkalaemic cardiac arrest successfully treated with peritoneal dialysis.

Authors:  M A Jackson; R Lodwick; S G Hutchinson
Journal:  BMJ       Date:  1996-05-18

2.  In my opinion: a debate--can succinylcholine be used routinely with safety in children?

Authors:  S K Woelfel; R C Morell; J M Berman
Journal:  J Clin Monit       Date:  1994-11

3.  Succinylcholine.

Authors:  D R Bevan
Journal:  Can J Anaesth       Date:  1994-06       Impact factor: 5.063

Review 4.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

5.  Complications during anaesthesia in patients with Duchenne's muscular dystrophy (a retrospective study)

Authors:  U T Larsen; B Juhl; O Hein-Sörensen; B de Fine Olivarius
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

6.  Duchenne muscular dystrophy and malignant hyperthermia--two case reports.

Authors:  J M Wang; T H Stanley
Journal:  Can Anaesth Soc J       Date:  1986-07

7.  Succinylcholine-induced cardiac arrest in unsuspected Duchenne muscular dystrophy.

Authors:  W A Henderson
Journal:  Can Anaesth Soc J       Date:  1984-07

8.  Succinylcholine-induced cardiac arrest in children with undiagnosed myopathy.

Authors:  M Sullivan; W K Thompson; G D Hill
Journal:  Can J Anaesth       Date:  1994-06       Impact factor: 5.063

9.  Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent.

Authors:  Xiangjun Zhang; Qian Cheng; Lanlan Li; Liqing Shangguan; Chenwen Li; Shengke Li; Feihe Huang; Jianxiang Zhang; Ruibing Wang
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.